4D Molecular Therapeutics Inc (FDMT)
26.40
+1.06
(+4.16%)
USD |
NASDAQ |
May 02, 16:00
26.40
0.00 (0.00%)
After-Hours: 17:21
4D Molecular Therapeutics Market Cap: 1.314B for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.262B |
| April 30, 2024 | 1.191B |
| April 29, 2024 | 1.207B |
| April 26, 2024 | 1.157B |
| April 25, 2024 | 1.171B |
| April 24, 2024 | 1.207B |
| April 23, 2024 | 1.235B |
| April 22, 2024 | 1.314B |
| April 19, 2024 | 1.257B |
| April 18, 2024 | 1.234B |
| April 17, 2024 | 1.259B |
| April 16, 2024 | 1.332B |
| April 15, 2024 | 1.307B |
| April 12, 2024 | 1.312B |
| April 11, 2024 | 1.379B |
| April 10, 2024 | 1.341B |
| April 09, 2024 | 1.349B |
| April 08, 2024 | 1.431B |
| April 05, 2024 | 1.424B |
| April 04, 2024 | 1.376B |
| April 03, 2024 | 1.390B |
| April 02, 2024 | 1.393B |
| April 01, 2024 | 1.494B |
| March 28, 2024 | 1.586B |
| March 27, 2024 | 1.786B |
| Date | Value |
|---|---|
| March 26, 2024 | 1.695B |
| March 25, 2024 | 1.673B |
| March 22, 2024 | 1.673B |
| March 21, 2024 | 1.682B |
| March 20, 2024 | 1.668B |
| March 19, 2024 | 1.594B |
| March 18, 2024 | 1.545B |
| March 15, 2024 | 1.569B |
| March 14, 2024 | 1.462B |
| March 13, 2024 | 1.463B |
| March 12, 2024 | 1.420B |
| March 11, 2024 | 1.421B |
| March 08, 2024 | 1.472B |
| March 07, 2024 | 1.469B |
| March 06, 2024 | 1.407B |
| March 05, 2024 | 1.346B |
| March 04, 2024 | 1.431B |
| March 01, 2024 | 1.462B |
| February 29, 2024 | 1.395B |
| February 28, 2024 | 1.388B |
| February 27, 2024 | 1.489B |
| February 26, 2024 | 1.444B |
| February 23, 2024 | 1.353B |
| February 22, 2024 | 1.300B |
| February 21, 2024 | 1.315B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
183.46M
Minimum
Jun 16 2022
1.786B
Maximum
Mar 27 2024
709.86M
Average
694.60M
Median
Market Cap Benchmarks
| Catalent Inc | 10.18B |
| Cytokinetics Inc | 6.628B |
| Vertex Pharmaceuticals Inc | 103.35B |
| Karyopharm Therapeutics Inc | 124.27M |
| Minerva Neurosciences Inc | 16.78M |
Market Cap Related Metrics
| PS Ratio | 49.75 |
| Price to Book Value | 4.270 |
| Price | 26.40 |
| Earnings Yield | -10.07% |